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Accessible interventions to train patients with chronic obstructive pulmonary disease
(COPD) are needed. We designed urban trails of different intensities (low, moderate and
high) in different types of public spaces (boulevard, beach and park). We aimed to validate
the trails’ design by assessing the physiological response to unsupervised walking trails of:
(1) different intensities in COPD patients, and (2) same intensity from different public spaces
in healthy adults.
Methods
On different days and under standardized conditions, 10 COPD patients walked the three
intensity trails designed in a boulevard space, and 10 healthy subjects walked the three
intensity trails in three different spaces. We measured physiological response and energy
expenditure using a gas analyzer. We compared outcomes across trails intensity and/or
spaces using mixed-effects linear regression.
Results
In COPD patients, physiological response and energy expenditure increased significantly
according to the trails intensity: mean (SD) peak _VO2 15.9 (3.5), 17.4 (4.7), and 17.7 (4.4)
mL/min/kg (p-trend = 0.02), and MET-min 60 (23), 64 (26), 72 (31) (p-trend<0.01) in low,
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moderate and high intensity trails, respectively. In healthy subjects there were no differences
in physiological response to walking trails of the same intensity across different spaces.
Conclusions
We validated the trails design for the training of COPD patients by showing that the physio-
logical response to and energy expenditure on unsupervised walking these trails increased
according to the predefined trails’ intensity and did not change across trails of the same
intensity in different public space. Walkable public spaces allow the design of trails that
could be used for the training of COPD patients in the community.
Introduction
Chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity and mortal-
ity worldwide [1,2]. The regular practice of physical activity improves COPD prognosis by
reducing the risk of COPD exacerbations and mortality [3]. Hence, physical activity constitutes
an important outcome in COPD management. In contrast, research about interventions
designed to increase physical activity in COPD patients is relatively still scarce, of poor quality
and/or shows inconsistent results [3].
Recent findings support regular walking as a training modality to increase physical activity
in COPD patients. Ground-based indoor, Nordic and standard supervised walking trainings
have been shown to result in physiological benefits [4–6]. Importantly, walking is an extended
practice well integrated into the daily life routine of the elderly in many countries [7–10].
Therefore, interventions promoting walking in public spaces are accessible to a wider range of
patients than hospital-based programs [11] and are more conducive to compliance because
they easily fit into patients’ daily life.
To our knowledge, only two studies have assessed walking in public spaces to train COPD
patients. Breyer et al. reported an improvement in exercise capacity in COPD patients after a
supervised intervention of Nordic Walking [12]. Pleguezuelos et al. observed that COPD
patients who had received information about urban walking circuits after a rehabilitation pro-
gram improved exercise capacity as compared to those who were not informed [13]. However,
it is not yet known whether unsupervised walking can induce a training effect.
We hypothesized that urban walkable public spaces allow the design of trails that could be
used for the training of COPD patients in unsupervised conditions. As part of the Urban Train-
ing™ on-going clinical trial (NCT01897298) we designed urban trails of different intensities
(low, moderate and high) for the training of COPD patients in different types of walkable pub-
lic spaces (boulevard, beach and park). The present study aimed to validate the design of trails
by assessing the physiological response to and the energy expenditure on unsupervised walking
trails of different intensities in COPD patients. As a secondary objective, we also assessed the




We recruited 10 clinically stable patients with a diagnosis of COPD according to the American
Thoracic Society and European Respiratory Society (ATS/ERS) criteria [14] from the
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outpatient clinics of Hospital del Mar, Barcelona. Exclusion criteria were: musculoskeletal limi-
tation for walking, use of long-term oxygen therapy and intolerance of the facemask. For the
secondary objective, we recruited 10 healthy subjects from the Centre for Research in Environ-
mental Epidemiology (CREAL), Barcelona. We excluded subjects with a diagnosis of any
chronic condition that could affect exercise capacity and/or heart rate. The study and the use of
oral consent were approved by the Clinical Research Ethical Committee of Parc de Salut Mar,
and oral informed consent was obtained from all subjects. The individual in S2 Image has
given written informed consent to publish these case details.
Design of trails
Amultidisciplinary team formed by respiratory physiotherapists, pulmonologists, family phy-
sicians, sport science experts, epidemiologists and urban planners identified public spaces close
to the recruitment centers potentially suitable for designing walking trails. Following the
World Health Organization and the Healthy Cities movement recommendations [15,16] we
excluded spaces with at least one of the following environmental restrictions that might nega-
tively influence walking [15–21]: (i) no accessibility by public transportation; (ii) lack of vegeta-
tion; (iii) absence of benches or fountains; (iv) presence of very long or high slopes; (v) paucity
of elements that facilitate exercise intensity (stairs, ramps or sand); (vi) high levels of pollution,
noise or car traffic; and, (vii) safety or criminality issues. Ultimately, we selected three types of
walkable public spaces: boulevard, beach and park.
In each space, we measured all urban elements of intensity (stairs, ramps and types of sur-
facing) in terms of length, slope and height using a laser rangefinder (Bosch PLR 50, Robert
Bosch GmbH, Germany). In parallel, we developed an ad hoc scoring table to classify the inten-
sity of each urban element based on the energy expenditure requirements for the physical activ-
ities that each urban element demanded, namely: walking on level ground, stair/slope climbing
and descending and walking on sand [22].
Finally, we designed 3 intensity trails (low, moderate and high) at each public space, com-
bining the urban elements previously scored. In order to facilitate access and achieve a training
effect, we designed all trails as continuous and circular, with several points of access and with
no traffic lights or other obstacles to walking (see S1 Text, which includes more details on
length, content and depiction of the trails; see S1 Table, describing characteristics of the three
intensity trails of each three public spaces; see S1 Image, reproducing the trails from a boule-
vard, beach and park space).
Study design and Procedures
The study was structured over four different days with at least one resting day in-between. On
Day 1, COPD patients performed a 6-min walking test (6MWT). On Days 2 to 4, they walked
on the low, moderate and high intensity trails from a boulevard space (total of 3 trails) in ran-
dom order, using random numbers generated with Stata 9.1 (StataCorp, College Station, TX,
USA). Patients received trails maps and were informed about the position, frequency and char-
acteristics of intensity elements and were instructed by the technicians to maintain a constant
self-regulated walking speed during the trail. Before starting, they stood up for 2 min at the
starting point. During the walk, two members of the research team walked 2 m behind the
patients without interfering in their pace. If patients needed to stop for resting, they could sit
on a portable chair carried by technicians. The walking period ended when patients reached
again the starting point or decided to stop walking due to symptoms. Thereafter, they recov-
ered silently while sitting for 5 min (see S2 Image showing a COPD patient walking on level,
climbing stairs and resting in a trail).
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To avoid overloading the COPD patients, young healthy subjects were asked to walk on the
three intensity trails (low, moderate and high) of the three types of walkable public spaces
(boulevard, beach and park; total of 9 trails) to answer the secondary objective. Instructions
and procedures were standardized as for the COPD patients.
Measurements
We collected the following information: sociodemographic and clinical data by using question-
naires and medical records, weight and height by physical examination, dyspnea by the modi-
fied Medical Research Council scale (mMRC, 0 to 4), lung function by forced spirometry with
bronchodilator response, and exercise capacity by the 6MWT following standards [23]. In
COPD patients, during the 6MWT and the walks on the trails, a portable gas analyzer (Meta-
Max1 3B, CORTEX, Germany) with a facemask, adjusted to patient’s face size, collected
breath-by-breath oxygen uptake per weight ( _VO2), carbon dioxide production ( _VCO2), venti-
lation ( _VE) and the energy expenditure measured by Metabolic Equivalent Tasks (METs).
Both in COPD patients and healthy subjects, heart rate (HR) during walks was obtained from a
Polar Belt (Polar RS800CX, Polar Electro, Finland). We measured dyspnea and lower limb
fatigue using modified Borg scale [24] immediately after 6MWT and each walk. We also mea-
sured the steps during trails using an electronic step counter (Walking style X Omron, Japan).
Data collection followed strict quality control procedures, including calibration of the gas ana-
lyzer before each test and check of on-line telemetry data recorded by the gas analyzer.
Statistical Analysis
Sample size was estimated with the program GRANMO7.10 [25] using _VO2 as the primary out-
come measure. Using a standard deviation of _VO2 in COPD patients of 3 mL/min/kg [26],
accepting an alpha risk of 0.05 and a beta risk of 0.2 in a two-sided test for repeated measures, a
total of 5 subjects would be sufficient to detect a statistically significant difference in _VO2 between
trails higher than or equal to 4 mL/min/kg, which has previously been reported between activities
of low and moderate intensity, and between moderate and high intensity activities [26]. The cal-
culated figure was increased up to 10 patients. For the secondary objective with healthy subjects,
peak HR was used as the primary outcome measure. Using data from the literature [27] and the
same statistical assumptions, a total of 8 subjects were required, which was rounded up to 10.
The subjects’ characteristics and physiological response to walks and 6MWT are presented as
frequencies and percentages for qualitative variables, mean and SD for normal distributed quanti-
tative variables and median and 25th-75th percentiles for non-normal distributed quantitative
variables. We compared variables of physiological response across trails intensity and/or space
using mixed-effects linear regression models, accounting for repeated observations within subject.
In COPD patients, the primary outcomes were the peak of relative _VO2, _VE, HR, and METs-
min. Secondary outcomes included time walking, time for breaks, walking speed, and total num-
ber of steps during the walk, as well as dyspnea and fatigue Borg scores at the end of the walks. In
healthy subjects, the primary outcome was the peak HR achieved during the walks. Walking
speed and dyspnea and fatigue Borg scores at the end of the walks were included as secondary
outcomes. All analyses were conducted using Stata 9.1 (StataCorp, College Station, TX, USA).
Results
Comparison of trails’ intensity—COPD patients
Patients were mostly male with normal BMI, and had mild (n = 1), moderate (n = 3), severe
(n = 4) and very severe (n = 2) spirometric grades of COPD (Table 1). All of them completed
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the 6MWT and three intensity trails. One high intensity walk was excluded from the analysis
due to technical problems with the gas analyzer sensor.
Table 2 shows that in COPD patients the peak values of _VO2, _VCO2, _VE, and HR increased
significantly according to the trails’ intensity as also did energy expenditure (MET-min), duration
of walking, walking speed and number of steps. However, the differences in physiological response
between moderate and high intensity trails were not statistically significant (see S2 Table). The
physiological response was higher in patients with severe-to-very severe COPD as compared to
patients with mild-to-moderate COPD, but small sample size prevents against any formal statisti-
cal test. The physiological response to walking the low intensity trail was similar to that of the
6MWT, and walking the moderate or high intensity trails generated a statistically higher physio-
logical demand (see S3 Table, comparing 6MWTwith walking trails). On the low intensity trail, 9
patients maintained a walking speed of over 80% of the average speed achieved during the
6MWT; by contrast, on both moderate and high intensity trails, 7 patients achieved this.
Comparison of spaces–Healthy subjects
The characteristics of young healthy subjects are shown in Table 1. Fifty percent were male and
had normal BMI. All completed the 9 trails and no technical problems appeared. Table 3
Table 1. Sociodemographic and clinical characteristics of COPD patients and healthy subjects.
COPD patients n = 10 Healthy subjects n = 10
Men, n 9 5
Age (years), m (SD) 67 (9) 31 (4)
Weight (kg), m (SD) 68 (13) 66 (8)
Height (m), m (SD) 1.67 (0.09) 1.71 (0.09)




Chronic heart failure 3 0
Diabetes 2 0
Current smoker, n 1 1




FEV1 (% predicted), m (SD) 41 (18) 102 (11)
FEV1 (l), m (SD) 1.2 (0.5) 3.9 (0.6)
FVC (% predicted), m (SD) 67 (13) 103 (12)
FEV1/FVC (% ratio), m (SD) 44 (14) 81 (4)
TLC (% predicted), m (SD) 98 (18) 
IC (% predicted), m (SD) 48 (19) 
RV (% predicted), m (SD) 166 (55) 
DLco (% predicted), m (SD) 51 (22) 
DLco/VA (% predicted), m (SD) 63 (17) 
6MWD (meters), m (SD) 448 (91) 
BMI: Body Mass Index; mMRC: Modified Medical Research Council; FEV1: forced expiratory volume in one second post bronchodilator; FVC: forced vital
capacity post bronchodilator; TLC: total lung capacity; IC: inspiratory capacity; RV: residual volume; DLco: diffusion capacity of the lung for carbon
monoxide; DLco/VA: diffusion capacity of the lung for carbon monoxide to alveolar volume ratio; 6MWD: six min walking distance.
doi:10.1371/journal.pone.0146705.t001
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shows no differences across trail spaces in the physiological and clinical response to walking
trails of the same intensity. Peak HR increased steadily with trail intensity: mean (SD) 108 (10),
117 (10), and 123 (13) beats/min during low, moderate and high intensity trails, respectively
(p-trend<0.001).
Discussion
To our knowledge, this is the first study validating and testing the potential of self-paced walk-
ing trails designed in public spaces as a training method for COPD patients and it has produced
two key findings. Firstly, both physiological response and energy expenditure in COPD
patients increase with the trails’ intensity. Secondly, there were no observable differences in
Table 2. Physiological and clinical response to walks on three intensity trails in COPD patients.
Low intensity trail Moderate intensity trail High intensity trail p-trend
Peak V_O2 (mL/min/kg), m (SD) 15.9 (3.5) 17.4 (4.7) 17.7 (4.4) 0.02
Peak V_CO2 (mL/min/kg), m (SD) 13.3 (4.6) 14.7 (5.5) 15.1 (4.4) 0.02
Peak RER, m (SD) 1.0 (0.1) 1.1 (0.2) 1.0 (0.1) 0.48
Peak V_E (L/min), m (SD) 33.7 (5.1) 35.3 (6.7) 36.6 (7.2) <0.01
Peak HR (beats/min), m (SD) 120 (18) 125 (20) 126 (20) 0.01
Energy expenditure volume (MET-min), m (SD) 60 (23) 64 (26) 72 (31) <0.01
Walking time (s), m (SD) 994 (258) 1087 (337) 1136 (290) <0.01
Walking speed (m/s), m (SD) 1.2 (0.3) 1.1 (0.3) 1.1 (0.3) <0.01
Steps (n), m (SD) 1789 (536) 1856 (708) 2001 (576) <0.01
Time for breaks (s), m (SD) 42 (101) 60 (91) 59 (112) 0.18
Final dyspnea (Borg score), median (p25-p75) 3 (2–4) 4 (3–5) 4 (3–5) 0.02
Final leg fatigue (Borg score), median (p25-p75) 2 (0–4) 2 (0–4) 2 (1–2) 0.21
V_O2: oxygen uptake; V
_CO2: carbon dioxide production; RER: respiratory exchange ratio; V
_E: min ventilation; HR: heart rate; MET: Metabolic Equivalent of
Task.
doi:10.1371/journal.pone.0146705.t002
Table 3. Physiological and clinical response on identical intensity trails from three public spaces (boulevard, beach and park) in healthy subjects.
Low intensity trail Boulevard Beach Park p-value
Peak HR (beats/min), m (SD) 110 (13) 107 (9) 108 (8) 0.74
Walking speed (m/s), m (SD) 1.5 (0.2) 1.7 (0.2) 1.6 (0.2) 0.03
Final dyspnea (Borg score), median (p25-p75) 0 (0–1) 0 (0–0) 0 (0–0) 0.40
Final leg fatigue (Borg score), median (p25-p75) 0 (0–2) 1 (0–2) 1 (0–2) 0.75
Moderate intensity trail Boulevard Beach Park p-value
Peak HR (beats/min), m (SD) 120 (9) 114 (10) 116 (10) 0.40
Walking speed (m/s), m (SD) 1.5 (0.1) 1.7 (0.2) 1.5 (0.1) 0.02
Final dyspnea (Borg score), median (p25-p75) 0 (0–1) 0 (0–0) 0 (0–0) 0.36
Final leg fatigue (Borg score), median (p25-p75) 1 (0–1) 1 (1–2) 1 (1–2) 0.57
High intensity trail Boulevard Beach Park p-value
Peak HR (beats/min), m (SD) 119 (12) 118 (10) 130 (15) 0.07
Walking speed (m/s), m (SD) 1.5 (0.1) 1.6 (0.2) 1.6 (0.2) 0.08
Final dyspnea (Borg score), median (p25-p75) 0 (0–1) 0 (0–1) 0 (0–1) 0.91
Final leg fatigue (Borg score), median (p25-p75) 1 (1–2) 2 (1–2) 2 (1–3) 0.71
HR: heart rate.
doi:10.1371/journal.pone.0146705.t003
Validation of Walking Trails for the Urban Training of COPD Patients
PLOS ONE | DOI:10.1371/journal.pone.0146705 January 14, 2016 6 / 11
physiological response amongst the healthy control subjects to trails of the same intensity in
the three different types of public spaces, validating the consistency of the methodology used
for the trails’ design. These two findings deserve further interpretation.
First, the increase in _VO2, peak _VE and peak HR and MET-min according to the trails’
intensity was expected because by design we increased frequency, length and/or slope of urban
elements (stairs, ramps and types of surfacing) which overall augment the trails’ intensity. It is
interesting to note that the trail’s different contents (in terms of urban elements) could lead to
different patterns of physiological response. For example, in our case study for COPD patients
(the boulevard trail) there were small differences in physiological responses between moderate
and high intensity trails which were not statistically significant. This could be attributed to sev-
eral factors, such as the small sample size combined with small effect difference and large vari-
ability of outcomes, or the use of absolute parameters of intensity instead of relative to the
maximal capacity of each patient. These factors should be acknowledged as limitations of the
current research. Also, the fact that patients were instructed to keep a self-regulated pace could
have made them adapting to the high intensity trail by reducing speed, increasing resting time
or simply not finishing the walk. This suggests that the future use of such urban trails for the
training of COPD patients needs to be accompanied with clear instructions of keeping a dys-
pnea Borg scale between 4 and 6, as recommended in traditional rehabilitation programs [11].
Finally, it could be argued that the frequency of stairs and ramps was increased between the
moderate and high intensity trail but without increasing their length or height (because the
space did not allow it). By contrast, the presence of sand on the beach trail resulted in higher
HR peak to be reached, as higher stairs did on the park trail. This would support that the vol-
ume of energy expenditure reflects better the level of the trails’ physiological demand than the
peak values of physiological response.
Our second observation relates to the physiological response while walking on each inten-
sity trail in young healthy subjects that did not vary across space types (boulevard, beach and
park). Our study highlights that urban elements, such as stairs, ramps and sand, can be stan-
dardized in terms of height, length and slope, thus allowing their combination to be used for
the design of trails in other geographical areas. How they are combined in terms of increased
frequency or increased length will depend on the possibilities of each public space.
Until now, research has been scarce in relation to the physiological demands that these
urban elements may present to in COPD patients when left to walk at their own-pace. Castro
et al. [26] showed that, in mild-to-very severe COPD patients, walking up or down 13 m of a
ramp at 10% inclination or 17 steps of stairs produced a 2 to 3-fold increase in _VO2 compared
to resting conditions. Similarly, Jeng et al. [28] found that walking on level ground and walking
upstairs required higher _VO2 than sitting or standing, although in this study the walking speed
was set by design. Barberan-Garcia et al. [6] showed in COPD patients that a 6-min Nordic
Walking test performed on sand generates significantly higher _VO2, _VE, HR, dyspnea and leg
fatigue values than the same test on firm ground. Along with these previous data, our findings
suggest that it is feasible to design trails for training COPD patients using stairs, ramps and
sand by capitalizing on the high energy expenditure that walking in these conditions demands
from these patients.
Several arguments suggest that physiological responses in COPD patients to walking trails
can be interpreted in terms of response to typical exercise training interventions. First, the
patients in the current study walked mostly at a speed of above 80% of the average speed
achieved during 6MWT, which has been proposed as a target for walking training [5,29]. Sec-
ondly, our patients achieved a mean of 4 points on the Borg dyspnea scale after all trails, in
keeping with the 4 to 6 score often considered a target for training intensity [11]. Altogether
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our findings suggest that walking on the Urban TrainingTM trails, when appropriately
designed, could be used as an effective training intervention for COPD patients customizing
individually the duration, frequency and intensity of the interventions, thus embracing the
large variability in individual goals and possibilities.
From a public health viewpoint, our approach offers the possibility of training to a vast
majority of COPD patients irrespective of their individual characteristics. This is specifically
relevant for the mild-to-moderate COPD patients due to two identified factors: (1) they do not
usually have access to the conventional tertiary-based training interventions because the latter
are prescribed usually in advanced stages of the disease; and (2) they cannot benefit from public
policies targeted at the general population because the resulting walking routes are not adapted
to the physiological and functional limitations of the disease population, principally because of
their excessive length (mean (SD) 3.4 (0.7) km) [30,31], or steep slopes and stairs.
Strengths of our study were the standardization of the methodology used to design the trails,
which included visiting the spaces, measuring urban elements, scoring and categorizing their
intensity and finally combining them. Similarly, we measured physiological response directly
by a device that provides several outcomes of energy expenditure that have been previously
used in COPD patients[6]. We carefully standardized data collection by randomizing the order
of the trails’ intensity in the different public spaces, and taking into account atmospheric condi-
tions and patients’ clinical status. The current study has also limitations. First, the lack of a
maximal exercise test precluded the use of relative values of exercise intensity that could have
helped in the interpretation of the data. However, the burden on COPD patients was already
too high because of the need for four days for different walking-related activities, and the
6MWT is accepted as a standardized and reliable tool that provides valuable information in
terms of exercise capacity. Second, the external validity of the study may be challenged because
both patients and healthy subjects were volunteers, but they were not selected on the basis of
their physical activity or exercise capacity levels. Finally, the exclusion of patients on long-term
oxygen therapy (because of its incompatibility with the gas analyzer) prevents extrapolating
the current results to the most severe subset of COPD patients.
In conclusion, we validated the trails design for the training of COPD patients by showing
that the physiological response and the energy expenditure on unsupervised walking on these
trails increased according to the predefined trails’ intensity and did not change across trails of
the same intensity and different public space. Interventions combining walking these trails
with other strategies, such as behavioral change interventions, may be a feasible and effective
way to promote physical activity for COPD patients in the community.
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